The global companion diagnostics market is forecast to grow at a compound annual growth rate (CAGR) of more than 10% during the forecast period from 2021-2030.
The companion diagnostic is a medical device that helps ensure the safe and effective use of a corresponding biological product or drug. Diagnostic tests such as these help doctors determine whether a particular treatment is beneficial to patients and whether any potential risks outweigh its benefits.
Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=Pol218
According to data from the U.S. Bureau of Economic Analysis and the U.S. Census Bureau, the goods and services deficit increased by $1.9 billion from $68.7 billion in January 2023 to $70.5 billion in February. The increase in the goods and services deficit in February was due to a $2.7 billion increase in the goods deficit to $93.0 billion and a $0.8 billion increase in the services surplus to $22.4 billion. Compared to the same period in 2022, the goods and services deficit has dropped this year by $35.5 billion, or 20.3%. $49.5 billion or 10.8% more was exported. 2.2% or $14.0 billion more was spent on imports.
Factors Affecting
- Personalized medicines are becoming a reality with the help of evidence-based laboratory analysis and companion diagnostics. A rise in the demand for customized drugs will fuel significant growth for the companion diagnostics market.
- The use of companion diagnostics in personalized medicine and drug development is making clinical trials more cost-effective. Thus, as the number of clinical trials increases, so will the demand for companion diagnostics.
- The primary use of Companion diagnostics is in cancer treatment, which already has a high treatment cost, and their use increases patients’ overall medical expenses. Due to this, the global companion diagnostics market slows down by the high price of diagnostic kits.
Impact Analysis of COVID-19
The major players in the companion diagnostics market with a robust supply management system are Roche Diagnostics, Agilent Technologies, Qiagen, Thermo Fisher, and Abbott Laboratories. They have an equal distribution of production facilities across countries. However, the COVID-19 outbreak and the social distancing restrictions have had a negative impact on the market for companion diagnostics. The nationwide lockdown enacted by the government has hindered supply and reduced availability.
Although the COVID-19 crisis threatens the market, there is also a favorable opportunity, as medical diagnostics companies are increasing their products and services to healthcare professionals. In addition, companion diagnostic testing kits have become increasingly popular to determine the safety and effectiveness of COVID-19 medicines for cancer patients receiving treatment.
Regional Analysis
North America held dominance in the global companion diagnostics industry. In North America, the market is experiencing high growth because of well-established healthcare systems and technological advances. Several Pharma and biotech companies contribute significantly to the rapid growth of companion diagnostics in North America. Moreover, the United States anticipates seeing an increase in the number of cancer patients in the coming years, which will spur the growth of companion diagnostics.
Get a Sample PDF copy of the report :-https://reportocean.com/industry-verticals/sample-request?report_id=Pol218
Europe is experiencing rapid expansion due to its highly efficient healthcare workforce and infrastructure. The regional market is also forecast to grow due to increasing awareness regarding the importance of precise diagnostic tools, electronic health records, and drugs prescribed specifically for a disease. Europe also spends a lot of money on healthcare. In addition, the public and private sectors are investing in R&D, and there is a well-developed healthcare sector in the region, which is driving growth.
Leading Competitors
The leading prominent players in the global companion diagnostics market are:
- Abbott Laboratories, Inc. (U.S.)
- Abnova Corporation (Taiwan)
- Agilent Technologies, Inc. (U.S.)
- Almac Group (U.K.)
- Biogenex Laboratories, Inc. (U.S.)
- bioMerieux S.A. (France)
- Danaher Corporation (U.S.)
- F. Hoffmann-La Roche AG (Switzerland)
- Guardant Health, Inc. (U.S.)
- Icon Plc (Ireland)
- Illumina, Inc. (U.S.)
- Myriad Genetics, Inc., (U.S.)
- QIAGEN N.V. (Germany)
- Sysmex Corporation (Japan)
- Thermo Fisher Scientific Inc. (U.S.)
- Other Prominent Players
Scope of the Report
The global companion diagnostics market segmentation includes Product, Technology, Indication, End-User, and Region.
Segmentation based on Product
- Assay kits & Reagents
- Software & Services
- Segmentation based on Technology
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization (ISH)
- Next-Generation Sequencing (NGS)
- Immunohistochemistry (IHC)
- Others (Multiplex Assay and Cellular Imaging Technologies)
Segmentation based on Indication
- Cardiovascular
- Neurological Diseases
- Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Gastric Cancer
- Infectious Diseases
- Others (inflammatory and inherited diseases)
Segmentation based on End-User
- Pharmaceutical & Biopharmaceutical Companies
- Reference Laboratories
- CROs
- Others
Request Full Report :-https://reportocean.com/industry-verticals/sample-request?report_id=Pol218
Segmentation based on Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- Western Europe
- The UK
- Germany
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Poland
- Russia
- Rest of Eastern Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
- South America
- Brazil
- Argentina
- Rest of South America
Aim of the Report
- This study aims to determine the market size of various segments and countries with forecast values for next ten years.
- Within the regions and countries studied, the report covers both qualitative and quantitative aspects of the industry.
- It also provides detailed information about the crucial aspects such as drivers & challenges that will influence the market’s future growth.
- The report will also include investment opportunities in micro markets for stakeholders. In addition, an in-depth analysis of key players’ products and the competitive landscape.
What is the goal of the report?
-The market report presents the estimated size of the Healthcare market at the end of the forecast -period.
-The report also examines historical and current market sizes.
-During the forecast period, the report analyzes the growth rate, market size, and market valuation.
-The report presents current trends in the industry and the future potential of the North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa markets.
-The report offers a comprehensive view of the market based on geographic scope, market segmentation, and key player financial performance.
Full Report Description, TOC, Table of Figure, Chart, etc.-https://reportocean.com/industry-verticals/sample-request?report_id=Pol218
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Report Ocean:
Email:sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES Tel: +1 888 212 3539 (US – TOLL FREE)
Website:https://www.reportocean.com/